Selective Laser Trabeculoplasty (SLT)
Selective Laser Trabeculoplasty (SLT) is an advanced laser system that improves the flow of fluid in the eye, lowering eye pressure for patients with glaucoma.
Using a focused, narrow wavelength, SLT targets specific cells of the eye — those containing melanin, a natural pigment — leaving surrounding cells intact. The procedure is painless and has no side effects, although patients are given anti-inflammatory eye drops before and after treatment. Eye pressure may drop as quickly as a day after the procedure.
Benefits of SLT
- Safe: SLT is not associated with systemic side effects or the compliance and cost issue of medications.
- Selective: SLT utilizes selective photothermolysis to target only specific cells, leaving the surrounding tissue intact.
- Smart: SLT stimulates the body’s natural mechanisms to enhance outflow of the fluid in your eye.
- Sensible: SLT therapy is reimbursed by Medicare and many other insurance providers, which minimizes your out-of-pocket expenses.
How SLT Works
Selective Laser Trabeculoplasty (SLT) is an advancement over other lasers that have been used safely and effectively in the treatment of open-angle glaucoma for more than two decades.
SLT works by using laser light to stimulate the body’s own healing response to lower your eye pressure. Using a special wave length and energy, the laser affects only pigmented (melanin containing) cells of your eye. SLT improves the flow of fluid in the eye, which in turn lowers your eye pressure. This 15 minute office procedure often reduces or eliminates the need for lifelong use of expensive eye drops.
Vision loss from glaucoma is permanent but can usually be prevented with early detection and treatment. Glaucoma management is usually a lifelong process that requires frequent monitoring and constant treatment. Since there is no way to determine if glaucoma is under control based on how a person feels, doctors visits should be on a regular basis.